TLR adaptor protein MYD88 mediates sensitivity to HDAC inhibitors via a cytokine-dependent mechanism

Histone deacetylase (HDAC) inhibitors have proven useful therapeutic agents for certain haematological cancers. However, HDAC inhibition causes diverse cellular outcomes, and identification of cancer-relevant pathways within these outcomes remains unresolved. In this study, we utilized an unbiased l...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: New, M, Sheikh, S, Bekheet, M, Olzscha, H, Thezenas, M, Care, M, Fotheringham, S, Tooze, R, Kessler, B, La Thangue, N
Formatua: Journal article
Hizkuntza:English
Argitaratua: American Association for Cancer Research 2016